MXCT Company Profile and Key Details
MaxCyte, Inc.
MXCT Stock Price Chart
Stock Price Today
MaxCyte, Inc. (MXCT) stock surged +3.45%, trading at $4.50 on NASDAQ, up from the previous close of $4.35. The stock opened at $4.32, fluctuating between $4.26 and $4.51 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company was incorporated in 1998 and is headquartered in Rockville, Maryland.
Company Information
| Employees | 143 |
| Beta | 1.16 |
| Sales or Revenue | $41.29M |
| 5Y Sales Change% | 0.228% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Devices |
Frequently Asked Questions
MaxCyte, Inc. (NASDAQ: MXCT) stock price is $4.50 in the last trading session. During the trading session, MXCT stock reached the peak price of $4.51 while $4.26 was the lowest point it dropped to. The percentage change in MXCT stock occurred in the recent session was 3.45% while the dollar amount for the price change in MXCT stock was $0.15.
The NASDAQ listed MXCT is part of Medical - Devices industry that operates in the broader Healthcare sector. MaxCyte, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. James Lovgren
Senior Vice President of Global Marketing
Mr. Thomas Michael Ross
Executive Vice President of Global Sales & Marketing
Dr. Cenk Sumen
Chief Scientific Officer
Mr. Ronald Evan Holtz CPA, Ph.D.
Executive Vice President of Admin.
Mr. Douglas Arthur Doerfler
Founder, Pres, Chief Executive Officer & Executive Director
Dr. Cenk Sumen Ph.D.
Chief Scientific Officer
Mr. Maher Masoud
Executive Vice President, Gen. Counsel & Sec.
Mr. Douglas J. Swirsky CFA, CPA
Chief Financial Officer
Mr. Sean Menarguez
Director of Investor Relations
Dr. J. Stark Thompson Ph.D.
Consultant
Dr. James Brady Ph.D.
Senior Vice President of Technical Applications & Customer Support
Dr. Sarah Haecker Meeks Ph.D.
Senior Vice President of Bus. Devel.
MXCT's closing price is 42.18% higher than its 52-week low of $3.17 where as its distance from 52-week high of $5.26 is -14.45%.
Number of MXCT employees currently stands at 143.
Official Website of MXCT is: https://maxcyte.com
MXCT could be contacted at phone 301 944 1700 and can also be accessed through its website. MXCT operates from 9713 Key West Avenue, Rockville, MD 20850, United States.
MXCT stock volume for the day was 338.29K shares. The average number of MXCT shares traded daily for last 3 months was 669.44K.
The market value of MXCT currently stands at $474.67M with its latest stock price at $4.50 and 105.48M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com